Leviticus Cardio featured in BioTuesdays

Leviticus Cardio developing wireless system to drive VADs

By Leonard Zehr, BioTuesdays (30 April 2019)

Closely-held Leviticus Cardio of Israel is developing a wireless system capable of providing day-to-day power needs for implanted ventricular assist devices (VADs), eliminating the complications that congestive heart failure (CHF) patients face with existing VADs.

Our solution uses a unique proprietary technology called, coplanar energy transfer (CET), that has the potential to work with all available commercial VADs.

VADs are increasingly in use to support patients with severe heart failure as an alternative for thousands of patients who are candidates for heart transplantation each year.

Leviticus Co-Founder & CEO Michael Zilbershlag, in an interview with BioTuesdays

Read the full article on BioTuesdays.